Your session is about to expire
← Back to Search
Renal Denervation + AF Ablation for Atrial Fibrillation (ULTRA-HFIB Trial)
ULTRA-HFIB Trial Summary
This trial is testing whether adding a renal sympathetic denervation procedure to standard AF ablation can help prevent AF recurrence.
ULTRA-HFIB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowULTRA-HFIB Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ULTRA-HFIB Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have a current drug or alcohol problem and can follow study instructions.I am 18 years old or older.I have a history of high blood pressure.I am scheduled for my first AF ablation procedure and it must be completed successfully before I can join.My AFib is caused by a heart valve issue or a temporary condition.I have only one working kidney.You are expected to live less than one year due to a medical condition.I have had atrial fibrillation for more than a year.I have high blood pressure and am on medication for it.I have had a procedure to correct heart rhythm problems before.I cannot have AF catheter ablation due to a heart clot or issues with blood thinners.I am not pregnant or nursing.My kidney function is reduced, with an eGFR below 40.I have severe heart failure.You are allergic to contrast dye and cannot be treated for the allergy.I have high blood pressure caused by another health condition.I have a chronic condition like Crohn's disease or ulcerative colitis.You have used other devices to treat high blood pressure before, such as the ROX Coupler, Mobius stent, or the CVRx barostimulator device.My kidney's blood vessels are not suitable for the treatment based on an angiography.I have had surgery on the left side of my heart.I've had a heart attack, unstable chest pain, stroke, or heart failure hospital visit in the last 3 months.
- Group 1: Catheter ablation + renal denervation
- Group 2: Catheter ablation only
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there multiple healthcare facilities in this city conducting the research project?
"This trial is being administrated at the Cleveland Clinic in Ohio, Mount Sinai Hospital in New york City and University of Arizona - Banner University Medical Center in Phoenix. In addition to these three medical centres, there are 10 other participating sites throughout the US."
Are participants still being accepted for this medical experiment?
"As indicated by the clinicaltrials.gov database, this medical experiment is presently recruiting participants. It was initially made available on July 8th 2020, and its latest revision was done on April 11th 2022."
What is the total enrollment for this medical study?
"To fulfill this clinical trial's requirements, 130 individuals who are eligible for participation must be recruited. Currently, recruitment is taking place in Cleveland Clinic located in Cleveland and Mount Sinai Hospital found in New york City."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger